The best semaglutide dose for weight loss varies according to your starting weight, risks, and stage of treatment. Read to ...

The US FDA approved the first generic referencing Victoza, a GLP-1 receptor agonist indicated to improve glycemic control.

A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?

The approval marks the second for a generic in this class of medications indicated to improve glycemic control in patients with type 2 diabetes as a complement to diet and exercise. The FDA today ...

This is the second GLP-1 receptor agonist to have a generic, following last month's approval of generic exenatide (referencing Byetta), a twice-daily injection. "The FDA supports development of ...